HMCD:LSE:LSE-HSBC MSCI China UCITS ETF (USD)

ETF | Others |

Last Closing

USD 6.98

Change

+0.11 (+1.53)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.75 (-2.49%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.84 (-0.70%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.08 (-0.45%)

USD 572.76B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.35%)

USD 266.08B
0QZO:LSE 0QZO

-1.05 (-1.09%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.82 (-2.77%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.12 (-0.38%)

USD 200.79B
0R24:LSE Intel Corp.

-0.35 (-1.47%)

USD 196.14B

ETFs Containing HMCD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.06% 93% A 86% B+
Dividend Return 2.54% 69% C- 83% B
Total Return 26.60% 94% A 88% B+
Trailing 12 Months  
Capital Gain 19.93% 63% D 64% D
Dividend Return 2.45% 61% D- 80% B-
Total Return 22.38% 68% D+ 67% D+
Trailing 5 Years  
Capital Gain -5.61% 23% F 35% F
Dividend Return 4.52% 52% F 63% D
Total Return -1.10% 22% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain -6.70% N/A N/A 18% F
Dividend Return -5.81% N/A N/A 20% F
Total Return 0.89% N/A N/A 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 24.27% N/A N/A 39% F
Risk Adjusted Return -23.93% N/A N/A 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike